Study S000637

MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07178145
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: RECRUITING
Enrollment: 192
Start: 2025-11-20
Primary completion: 2029-09
Lead sponsor: University of Virginia
Conditions: Heart Failure Preserved Ejection Fraction; Epicardial Adipose Tissue
Interventions: DRUG:GLP-1RA
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Epicardial adipose tissue (EAT) fatty acid composition (FAC) [Baseline, 3 months (self-control period), and 9-months (6 months post semaglutide treatment)]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010300	Epicardial adipose tissue in contemporary cardiology. Iacobellis G, Nature reviews. Cardiology	2022	Narrative review	PMID 35296869 DOI	registry reference BACKGROUND:35296869